Queenie Jang
Chief Executive Officer at ISCT
Meet Queenie Jang
“Specialized training and development to populate the highly skilled cell and gene therapy workforce remains an essential task to enable the continued growth of the sector. Despite the pandemic, cell and gene companies raised almost $20 billion in 2020, more than doubling the amount raised in 2019 (according to the ARM State of the Industry, Jan 2021). There will continue to be huge demand for a skilled and qualified workforce to develop and deliver these therapies, requiring strategic investment from all stakeholders in the sector.”